Abstract:Regulatory T (Treg) cells, characterized by expression of the transcription factor forkhead box P3 (Foxp3), maintain immune homeostasis by suppressing self-destructive immune responses1,2,3,4. Foxp3 operates as a late-acting differentiation factor controlling Treg cell homeostasis and function5, whereas the early Treg-cell-lineage commitment is regulated by the Akt kinase and the forkhead box O (Foxo) family of transcription factors6,7,8,9,10. However, whether Foxo proteins act beyond the Treg-cell-commitment stage to control Treg cell homeostasis and function remains largely unexplored. Here we show that Foxo1 is a pivotal regulator of Tregcell function. Treg cells express high amounts of Foxo1 and display reduced T-cell-receptor-induced Akt activation, Foxo1 phosphorylation and Foxo1 nuclear exclusion. Mice with Treg-cell-specific deletion of Foxo1 develop a fatal inflammatory disorder similar in severity to that seen in Foxp3-deficient mice, but without the loss of Treg cells. Genome-wide analysis of Foxo1 binding sites reveals ∼300 Foxo1-bound target genes, including the pro-inflammatory cytokine Ifng, that do not seem to be directly regulated by Foxp3. These findings show that the evolutionarily ancient Akt–Foxo1 signalling module controls a novel genetic program indispensable for Treg cell function. The results of a series of genetic experiments indicate that Foxo1 has a pivotal, Foxp3-independent role controlling regulatory T-cell function. Foxo transcription factors are known to be involved in the control of immune homeostasis at least up to the regulatory T (Treg)-cell commitment stage. This paper reveals a crucial role for Foxo1 in the control of Treg-cell-dependent immune tolerance, independent of Foxo3. The authors propose that Treg cells co-opt the evolutionarily ancient Akt–Foxo1 signalling pathway to control a novel genetic program essential for Treg-cell function. This raises the possibility that manipulating the Akt–Foxo1 signalling pathway might offer a treatment for Treg-cell-associated immunological disorders.

Transcription Factors Foxo3a and Foxo1 Couple the E3 Ligase Cbl-b to the Induction of Foxp3 Expression in Induced Regulatory T Cells

Novel Foxo1-dependent Transcriptional Programs Control Treg Cell Function

Foxp3 Enhancers Synergize to Maximize Regulatory T Cell Suppressive Capacity.

Transcriptional Regulation of Foxp3 Gene: Multiple Signal Pathways on the Road

T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

Foxd3 Suppresses Interleukin-10 Expression in B Cells.

Dynamic Foxp3-chromatin Interaction Controls Tunable Treg Cell Function.

TGF-β and IL-6 Signals Modulate Chromatin Binding and Promoter Occupancy by Acetylated FOXP3

Transcriptional regulation of Foxp3 in regulatory T cells

Inflammation-induced repression of chromatin bound by the transcription factor Foxp3 in regulatory T cells

Cyclin-dependent kinase 5 represses Foxp3 gene expression and Treg development through specific phosphorylation of Stat3 at Serine 727 (LYM8P.641)

Control of the Differentiation of Regulatory T Cells and TH17 Cells by the DNA-binding Inhibitor Id3

Control of regulatory T‐cell differentiation and function by T‐cell receptor signalling and Foxp3 transcription factor complexes

Control of Foxp3 Induction and Maintenance by Sequential Histone Acetylation and DNA Demethylation.

Nemo-like Kinase Drives Foxp3 Stability and is Critical for Maintenance of Immune Tolerance by Regulatory T Cells.

Foxp3, A Critical Mediator Of Regulatory T-Cell Function, Is Expressed In Subsets Of Myeloid Cells

The E3 Ubiquitin Ligase Itch Regulates Expression of Transcription Factor Foxp3 and Airway Inflammation by Enhancing the Function of Transcription Factor TIEG1.

Suppression of FOXP3 expression by the AP-1 family transcription factor BATF3 requires partnering with IRF4

Neither Smad2 or Smad3 is Essential for TGF-β to Induce Foxp3+ Tregs and Th17 (47.8)

TGF-β signaling controls Foxp3 methylation and T reg cell differentiation by modulating Uhrf1 activity.